Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo.

Roth L, Wakim J, Wasserman E, Shalev M, Arman E, Stein M, Brumfeld V, Sagum CA, Bedford MT, Tuckermann J, Elson A.

Sci Signal. 2019 Jan 8;12(563). pii: eaau0240. doi: 10.1126/scisignal.aau0240.

PMID:
30622194
2.

The roles of protein tyrosine phosphatases in bone-resorbing osteoclasts.

Shalev M, Elson A.

Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):114-123. doi: 10.1016/j.bbamcr.2018.07.005. Epub 2018 Jul 17. Review.

PMID:
30026076
3.

The PXDLS linear motif regulates circadian rhythmicity through protein-protein interactions.

Shalev M, Aviram R, Adamovich Y, Kraut-Cohen J, Shamia T, Ben-Dor S, Golik M, Asher G.

Nucleic Acids Res. 2018 Aug 21;46(14):7469-7470. doi: 10.1093/nar/gky629. No abstract available.

4.

Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.

Ben-Hail D, Begas-Shvartz R, Shalev M, Shteinfer-Kuzmine A, Gruzman A, Reina S, De Pinto V, Shoshan-Barmatz V.

J Biol Chem. 2016 Nov 25;291(48):24986-25003. Epub 2016 Oct 13.

5.

FOOT-AND-MOUTH DISEASE IN A SMALL SAMPLE OF EXPERIMENTALLY INFECTED PRONGHORN (ANTILOCAPRA AMERICANA).

Rhyan J, McCollum M, Gidlewski T, Shalev M, Ward G, Donahue B, Arzt J, Stenfeldt C, Mohamed F, Nol P, Deng M, Metwally S, McKenna T, Salman M.

J Wildl Dis. 2016 Oct;52(4):862-873. Epub 2016 Aug 15.

PMID:
27525593
6.

Compressive Fresnel holography approach for high-resolution viewpoint inference.

Rivenson Y, Shalev MA, Zalevsky Z.

Opt Lett. 2015 Dec 1;40(23):5606-9. doi: 10.1364/OL.40.005606.

PMID:
26625062
7.

Circadian Clock Control by Polyamine Levels through a Mechanism that Declines with Age.

Zwighaft Z, Aviram R, Shalev M, Rousso-Noori L, Kraut-Cohen J, Golik M, Brandis A, Reinke H, Aharoni A, Kahana C, Asher G.

Cell Metab. 2015 Nov 3;22(5):874-85. doi: 10.1016/j.cmet.2015.09.011. Epub 2015 Oct 8.

8.

Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics.

Shalev M, Rozenberg H, Smolkin B, Nasereddin A, Kopelyanskiy D, Belakhov V, Schrepfer T, Schacht J, Jaffe CL, Adir N, Baasov T.

Nucleic Acids Res. 2015 Sep 30;43(17):8601-13. doi: 10.1093/nar/gkv821. Epub 2015 Aug 11.

9.

The PXDLS linear motif regulates circadian rhythmicity through protein-protein interactions.

Shalev M, Aviram R, Adamovich Y, Kraut-Cohen J, Shamia T, Ben-Dor S, Golik M, Asher G.

Nucleic Acids Res. 2014 Oct 29;42(19):11879-90. doi: 10.1093/nar/gku873. Epub 2014 Sep 26.

10.
11.

Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.

Xue X, Mutyam V, Tang L, Biswas S, Du M, Jackson LA, Dai Y, Belakhov V, Shalev M, Chen F, Schacht J, J Bridges R, Baasov T, Hong J, Bedwell DM, Rowe SM.

Am J Respir Cell Mol Biol. 2014 Apr;50(4):805-16. doi: 10.1165/rcmb.2013-0282OC.

12.

Chronic Akt1 deficiency attenuates adverse remodeling and enhances angiogenesis after myocardial infarction.

Vandoorne K, Vandsburger MH, Raz T, Shalev M, Weisinger K, Biton I, Brumfeld V, Raanan C, Nevo N, Eilam R, Hemmings BA, Tzahor E, Harmelin A, Gepstein L, Neeman M.

Circ Cardiovasc Imaging. 2013 Nov;6(6):992-1000. doi: 10.1161/CIRCIMAGING.113.000828. Epub 2013 Oct 17.

PMID:
24134954
13.

Identification of the molecular attributes required for aminoglycoside activity against Leishmania.

Shalev M, Kondo J, Kopelyanskiy D, Jaffe CL, Adir N, Baasov T.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13333-8. doi: 10.1073/pnas.1307365110. Epub 2013 Jul 29.

14.

Structural and functional differences between pheromonotropic and melanotropic PK/PBAN receptors.

Hariton-Shalev A, Shalev M, Adir N, Belausov E, Altstein M.

Biochim Biophys Acta. 2013 Nov;1830(11):5036-48. doi: 10.1016/j.bbagen.2013.06.041. Epub 2013 Jul 10.

PMID:
23850474
15.

Development of generic immunoassay for the detection of a series of aminoglycosides with 6'-OH group for the treatment of genetic diseases in biological samples.

Shalev M, Kandasamy J, Skalka N, Belakhov V, Rosin-Arbesfeld R, Baasov T.

J Pharm Biomed Anal. 2013 Mar 5;75:33-40. doi: 10.1016/j.jpba.2012.11.014. Epub 2012 Nov 20.

16.

Sol-Gel Entrapped Levonorgestrel Antibodies: Activity and Structural Changes as a Function of Different Polymer Formats.

Shalev M, Miriam A.

Materials (Basel). 2011 Feb 25;4(3):469-486. doi: 10.3390/ma4030469.

17.

Monitoring of progestins: development of immunochemical methods for purification and detection of levonorgestrel.

Shalev M, Bardugo M, Nudelman A, Krol A, Schlesinger H, Bronshtein A, Altstein M.

Anal Chim Acta. 2010 Apr 30;665(2):176-84. doi: 10.1016/j.aca.2010.03.029. Epub 2010 Mar 23.

PMID:
20417328
18.

Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin.

Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A, Leibovitch I.

J Urol. 2008 Dec;180(6):2379-83. doi: 10.1016/j.juro.2008.08.006. Epub 2008 Oct 31.

PMID:
18950807
19.

[The role of nonoperative management of penetrating renal trauma].

Shefler A, Gremitzky A, Vainrib M, Tykochinsky G, Shalev M, Richter S, Erlich N, Schiwartz I, Leibovitch I.

Harefuah. 2007 May;146(5):345-8, 406-7. Hebrew.

PMID:
17674549
20.

Animal Enterprise Terrorism Act becomes law.

Shalev M.

Lab Anim (NY). 2007 Jan;36(1):15. No abstract available.

PMID:
17183333
21.

USDA revises policies on veterinary care and submission of annual reports.

Shalev M.

Lab Anim (NY). 2006 Oct;35(9):13. No abstract available.

PMID:
17008898
22.

Pending legislation would affect animal research in US.

Shalev M.

Lab Anim (NY). 2006 Sep;35(8):13. No abstract available.

PMID:
16943782
23.

EU to rework animal welfare rules.

Shalev M.

Lab Anim (NY). 2006 Sep;35(8):13. No abstract available.

PMID:
16943781
24.

OLAW issues guidance on the use of telecommunications for IACUC meetings.

Shalev M.

Lab Anim (NY). 2006 May;35(5):15. No abstract available.

PMID:
16645606
25.

APHIS, FDA, and NIH issue memorandum of understanding on laboratory animal welfare.

Shalev M.

Lab Anim (NY). 2006 Apr;35(4):13. No abstract available.

PMID:
16582888
26.

Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer.

Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, Wheeler TM, Miles BJ, Rauen K, Teh BS, Butler EB, Thompson TC, Kadmon D.

Mol Ther. 2006 Apr;13(4):716-28. Epub 2006 Feb 15.

27.

NIH announces final rules on ethics.

Shalev M.

Lab Anim (NY). 2005 Oct;34(9):17. No abstract available.

PMID:
16195728
28.
29.

USDA clarifies practice for certain adjudicatory proceedings.

Shalev M.

Lab Anim (NY). 2005 Jul-Aug;34(7):15. No abstract available.

PMID:
15995687
30.

New guidance on prompt reporting to OLAW under PHS Policy.

Shalev M.

Lab Anim (NY). 2005 Apr;34(4):18-9. No abstract available.

PMID:
15806082
31.

NIH updates regulations on conflict of interest.

Shalev M.

Lab Anim (NY). 2005 Apr;34(4):18. No abstract available.

PMID:
15806081
32.

New UK law allows stricter punishment of animal rights extremists.

Shalev M.

Lab Anim (NY). 2005 Mar;34(3):14. No abstract available.

PMID:
15735628
33.

New USDA animal identification system; OHS partnership continues.

Shalev M.

Lab Anim (NY). 2005 Feb;34(2):16. No abstract available.

PMID:
15685182
34.

USDA encourages humane slaughter of animals.

Shalev M.

Lab Anim (NY). 2004 Nov;33(10):14-5. Review. No abstract available.

PMID:
15514646
35.

Regulation updates.

Shalev M.

Lab Anim (NY). 2004 Sep;33(8):13. No abstract available.

PMID:
15334100
36.
37.

NIH to report to congress noncompliance with federal policy on animal research.

Shalev M.

Lab Anim (NY). 2003 Oct;32(9):14-5. No abstract available.

PMID:
15235651
38.

President signs 'National Veterinary Medical Service Act' and 'Captive Wildlife Safety Act'.

Shalev M.

Lab Anim (NY). 2004 Feb;33(2):13. No abstract available.

PMID:
15235636
39.

NIH revises rules of conflict of interest of grant peer reviewers.

Shalev M.

Lab Anim (NY). 2004 Mar;33(3):15-6. Review. No abstract available.

PMID:
15235618
40.

USDA publishes final rule on the definition of animal.

Shalev M.

Lab Anim (NY). 2004 Jul-Aug;33(7):15. No abstract available.

PMID:
15224107
41.

Patient-adjusted intermittent electrostimulation for treating stress and urge urinary incontinence.

Nissenkorn I, Shalev M, Radziszewski P, Dobronski P, Borkowski A, De Jong PR.

BJU Int. 2004 Jul;94(1):105-9.

42.

HHS proposes revised regulations on misconduct in research.

Shalev M.

Lab Anim (NY). 2004 Jun;33(6):12-3. No abstract available.

PMID:
15179427
43.

HHS creates new advisory board to improve biosecurity in "dual use" research.

Shalev M.

Lab Anim (NY). 2004 Apr;33(4):14. No abstract available.

PMID:
15141252
44.

NIOSH publishes occupational safety and health resources.

Shalev M.

Lab Anim (NY). 2004 May;33(5):13. No abstract available.

PMID:
15141235
45.

USDA to apply animal welfare regulations to foreign air carriers.

Shalev M.

Lab Anim (NY). 2004 Jan;33(1):15. Review. No abstract available.

PMID:
14752526
46.

European Commission proposes radical overhaul of animal transport rules.

Shalev M.

Lab Anim (NY). 2003 Sep;32(8):16. No abstract available.

PMID:
12966442
47.

USDA to require research facilities, dealers, and exhibitors to keep veterinary medical records.

Shalev M.

Lab Anim (NY). 2003 Jun;32(6):16. No abstract available.

PMID:
12817273
48.

Institutional policy on financial conflict of interest: objectivity in research.

Shalev M.

Lab Anim (NY). 2003 Apr;32(4):16-7. No abstract available.

PMID:
19753745
49.

Website to facilitate public participation in federal rulemaking process.

Shalev M.

Lab Anim (NY). 2003 Mar;32(3):18. No abstract available.

PMID:
12601383
50.

HHS, USDA establish new regulations for use of select biological agents.

Shalev M.

Lab Anim (NY). 2003 Feb;32(2):15-6. No abstract available.

PMID:
12545179

Supplemental Content

Loading ...
Support Center